Identifying Best Candidates for Bexarotene Therapy in Cutaneous T-Cell Lymphoma: Role of APOA5, APOC3 Genotypes
Screening for APOA5 and APOC3 polymorphisms may help physicians who treat patients with cutaneous T-cell lymphoma identify the best candidates for bexarotene treatment.